Sameness Evaluations in an ANDA — Active Ingredients
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 8, 2022
January 11, 2023
56e63be0-f1f7-48cf-90e1-c9eb340486ef
Related Documents
In Vitro Release Test Studies for Topical Drug Products Submitted in ANDAs
Guidance DocumentOctober 21, 2022Center for Drug Evaluation and Research
In Vitro Permeation Test Studies for Topical Drug Products Submitted in ANDAs
Guidance DocumentOctober 21, 2022Center for Drug Evaluation and Research
Evaluation of Therapeutic Equivalence
Guidance DocumentJuly 21, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.